Search research articles
Contact Us
Filters
Showing results (61-70 of 87) with videos related to
Page
of 9
Sort By:
Heart Rhythm
|
July 25, 2024
Appropriate and inappropriate ICD shocks in patients with LVADs: Prevalence, associated factors, and etiologies
Andrew Andreae, Eric Black-Maier, Kelly Arps, et al.
Journal of the American Heart Association
|
April 27, 2019
Comparison of Patient-Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT - AF Registry
Alexander C Perino, Peter Shrader, Mintu P Turakhia, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
December 17, 2013
Impact of pre-stage II hemodynamics and pulmonary artery anatomy on 12-month outcomes in the Pediatric Heart Network Single Ventricle Reconstruction trial
Ranjit Aiyagari, John F Rhodes, Peter Shrader, et al.
Circulation. Arrhythmia and Electrophysiology
|
December 14, 2019
Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation
James V Freeman, Peter Shrader, Karen S Pieper, et al.
JAMA Cardiology
|
November 13, 2017
Association of of Atrial Fibrillation Clinical Phenotypes With Treatment Patterns and Outcomes: A Multicenter Registry Study
Taku Inohara, Peter Shrader, Karen Pieper, et al.
Congenital Heart Disease
|
June 18, 2014
Survival data and predictors of functional outcome an average of 15 years after the Fontan procedure: the pediatric heart network Fontan cohort
Andrew M Atz, Victor Zak, Lynn Mahony, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
August 21, 2012
Cause, timing, and location of death in the Single Ventricle Reconstruction trial
Richard G Ohye, Julie V Schonbeck, Pirooz Eghtesady, et al.
Journal of the American Heart Association
|
February 18, 2018
Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II)
Benjamin A Steinberg, Peter Shrader, Karen Pieper, et al.
American Heart Journal
|
November 12, 2019
Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillation
Zak Loring, Peter Shrader, Larry A Allen, et al.
Circulation. Population Health and Outcomes
|
February 20, 2026
Variation in Lipid Management for Atherosclerotic Cardiovascular Disease Across US Health Systems
Nishant P Shah, Eric D Peterson, Peter Shrader, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 87) with videos related to
Sort By:
Page
of 9
Heart Rhythm
|
July 25, 2024
Appropriate and inappropriate ICD shocks in patients with LVADs: Prevalence, associated factors, and etiologies
Andrew Andreae, Eric Black-Maier, Kelly Arps, et al.
Journal of the American Heart Association
|
April 27, 2019
Comparison of Patient-Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT - AF Registry
Alexander C Perino, Peter Shrader, Mintu P Turakhia, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
December 17, 2013
Impact of pre-stage II hemodynamics and pulmonary artery anatomy on 12-month outcomes in the Pediatric Heart Network Single Ventricle Reconstruction trial
Ranjit Aiyagari, John F Rhodes, Peter Shrader, et al.
Circulation. Arrhythmia and Electrophysiology
|
December 14, 2019
Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation
James V Freeman, Peter Shrader, Karen S Pieper, et al.
JAMA Cardiology
|
November 13, 2017
Association of of Atrial Fibrillation Clinical Phenotypes With Treatment Patterns and Outcomes: A Multicenter Registry Study
Taku Inohara, Peter Shrader, Karen Pieper, et al.
Congenital Heart Disease
|
June 18, 2014
Survival data and predictors of functional outcome an average of 15 years after the Fontan procedure: the pediatric heart network Fontan cohort
Andrew M Atz, Victor Zak, Lynn Mahony, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
August 21, 2012
Cause, timing, and location of death in the Single Ventricle Reconstruction trial
Richard G Ohye, Julie V Schonbeck, Pirooz Eghtesady, et al.
Journal of the American Heart Association
|
February 18, 2018
Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II)
Benjamin A Steinberg, Peter Shrader, Karen Pieper, et al.
American Heart Journal
|
November 12, 2019
Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillation
Zak Loring, Peter Shrader, Larry A Allen, et al.
Circulation. Population Health and Outcomes
|
February 20, 2026
Variation in Lipid Management for Atherosclerotic Cardiovascular Disease Across US Health Systems
Nishant P Shah, Eric D Peterson, Peter Shrader, et al.
Page
of 9